Highlights
Profile claimed by owner
About
Medical-grade Cannabis Products
Canonic aims to develop and bring to market medical-grade cannabis using a genomic approach. The company will initially focus on creating improved cannabis varieties, focusing on yield, stability, and specific metabolite composition. The company is a subsidiary of Evogene. Canonics development efforts will be based on the utilization of Evogenes computational predictive biology platform, which has already demonstrated success in addressing similar objectives for other crops.
Identity
| Name | Canonic |
|---|---|
| Slug | canonic |
| Type / kind | startup |
| Crunchbase ID | canonic |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PiQkdcLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Oct 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Gad Feinstein Road 13, Rehovot, Israel |
Web & social
| https://www.linkedin.com/company/19105593 | |
| YouTube | https://www.youtube.com/channel/UCJzfbkfjVrkxc0brRKhj5zA |
Classifications
Primary sector Agriculture & Food Technologies
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisAgriculture & Food TechnologiesAg TechGenetics & Input
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B2CB2B
Tags
agtechartificial-intelligenceprecision-agriculturecannabismedical-cannabisbig-dataplant-genomicscropsbreedingnon-gmo
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}